Low Rates of Neurocognitive Impairment Are Observed in Neuro-Asymptomatic HIV-Infected Subjects on Effective Antiretroviral Therapy

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression

(2011) Lucette A. Cysique et al.   JOURNAL OF NEUROVIROLOGY

Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment‐Naive, HIV‐1–Infected Individuals Commencing cART? A Randomized, Controlled Study

(2010) Alan Winston et al.   CLINICAL INFECTIOUS DISEASES

Cerebral function tests reveal differences in HIV-infected subjects with and without chronic HCV co-infection

(2010) A. Thiyagarajan et al.   CLINICAL MICROBIOLOGY AND INFECTION

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System

(2008) Scott Letendre   ARCHIVES OF NEUROLOGY

Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region

(2008) E. Wright et al.   NEUROLOGY

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

(2007) Krishnan Bhaskaran et al.   ANNALS OF NEUROLOGY